entertainment -WSS

entertainment

author：hotspot 2025-09-29 23:27:56 - browse：45559

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： STAT Summit: GSK CEO on pharma giant's new direction

WSS

Bird flu outbreak in cows is latest avian flu curveball

STAT Summit: GSK CEO on pharma giant's new direction

STAT Summit: Michael J. Fox on progress in Parkinson's research

Eli Lilly expects to double planned employment in Boston center

Medical bills so high, Medicare adding extra digits to claim forms

H5N1 bird flu found in pasteurized milk: what we know

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

New air purifier tech could be key to improving indoor air quality

Cholera vaccine supply gets boost as demand surges globally

FDA approval of Sarepta Duchenne genetic therapy gives me hope

2023 STAT Wunderkinds: get to know the winners

State Dept. review finds Biden bears some blame for Afghanistan failures

CEOs share strategies for surviving biotech slump

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth financials solid despite Change Healthcare cyberattack

Tori Bowie and the unacceptable rates of Black maternal death

Orangutan used medicinal plant to treat wound, first time ever seen

entertainment

MultiPlan and major insurers sued for alleged medical price

How climate

MassMutual is introducing free genetic testing for members

FDA struggles to regulate food additives, sometimes for decades

Beam Therapeutics to lay off 20% of its staff, re

More tobacco lobbyists active in statehouses

focus

Wikipedia

leisure time

entertainment